Kensington Capital Acquisition Corp. VI has filed a proxy statement for an extraordinary general meeting aimed at approving a business combination with Nth Cycle Inc. This merger is poised to transform Kensington into Nth Cycle Holdings, Inc., effectively changing its jurisdiction from the Cayman Islands to Delaware.
This merger is a notable development in the industrial inorganic chemicals sector, reflecting a broader trend of consolidation within the industry. The implications of this merger may resonate with shareholders and stakeholders of both companies as they prepare for this significant transition.
Background
Kensington Capital Acquisition Corp. VI, identified by the SIC code 2810, operates within the industrial inorganic chemicals sector. The company trades on the NYSE under several tickers: KCAC-UN, KCAC-WT, and KCA-UN. Recent filings include a Form 424B3 submitted on November 10, 2026, which outlines the details of the proposed merger.
What the Filing Says
The filing indicates that on July 21, 2026, Kensington's board unanimously approved the Business Combination Agreement with Nth Cycle. The agreement includes plans for Kensington to deregister from the Cayman Islands and domesticate as a Delaware corporation. Additionally, the filing specifies that the merger will involve a series of transactions, including the conversion of shares and warrants, and will result in Nth Cycle becoming a wholly owned subsidiary of Kensington.
Impact
This merger is expected to impact shareholders of both Kensington and Nth Cycle. Shareholders of Kensington will have the opportunity to convert their shares into those of the newly formed Nth Cycle Holdings, Inc. The merger also highlights the increasing interest in sustainable and innovative solutions within the industrial sector, as Nth Cycle focuses on recycling and waste management technologies.
What's Next
The next steps involve obtaining shareholder approval for the merger. The filing does not specify a timeline for the vote or any further actions required following the meeting.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










